English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 127 | Tables: 118 | Medical Devices & Consumables
The global Exoskeleton Enhancement Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Exoskeleton Enhancement Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Exoskeleton enhancement device is an intelligent auxiliary bone system, which is designed based on bionics and ergonomics, and has an end-traction rehabilitation robot. Through the interaction between robot technology and human body, it can achieve human body strengthening, collaborative movement and rehabilitation treatment.
The North American market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Exoskeleton Enhancement Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Exoskeleton Enhancement Device include Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics, LockHeed Martin, Parker Hannifin, Interactive Motion Technologies, Panasonic, Myomo, B-TEMIA Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Exoskeleton Enhancement Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Exoskeleton Enhancement Device. The Exoskeleton Enhancement Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Exoskeleton Enhancement Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Exoskeleton Enhancement Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cyberdyne
Hocoma
ReWalk Robotics
Ekso Bionics
LockHeed Martin
Parker Hannifin
Interactive Motion Technologies
Panasonic
Myomo
B-TEMIA Inc.
Alter G
US Bionics
Segment by Type
Lower
Upper
Full Body
by Application
Healthcare
Defense
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Exoskeleton Enhancement Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Exoskeleton Enhancement Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Exoskeleton Enhancement Device Market Overview
1.1 Product Definition
1.2 Exoskeleton Enhancement Device by Type
1.2.1 Global Exoskeleton Enhancement Device Market Value by Type: 2025 vs 2032
1.2.2 Lower
1.2.3 Upper
1.2.4 Full Body
1.3 Exoskeleton Enhancement Device by Application
1.3.1 Global Exoskeleton Enhancement Device Market Value by Application: 2025 vs 2032
1.3.2 Healthcare
1.3.3 Defense
1.3.4 Others
1.4 Global Exoskeleton Enhancement Device Market Size Estimates and Forecasts
1.4.1 Global Exoskeleton Enhancement Device Revenue 2021–2032
1.4.2 Global Exoskeleton Enhancement Device Sales 2021–2032
1.4.3 Global Exoskeleton Enhancement Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Exoskeleton Enhancement Device Market Competition by Manufacturers
2.1 Global Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Exoskeleton Enhancement Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Exoskeleton Enhancement Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Exoskeleton Enhancement Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Exoskeleton Enhancement Device, Product Types and Applications
2.7 Global Key Manufacturers of Exoskeleton Enhancement Device, Date of Entry into the Industry
2.8 Global Exoskeleton Enhancement Device Market Competitive Situation and Trends
2.8.1 Global Exoskeleton Enhancement Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Exoskeleton Enhancement Device Players Market Share by Revenue
2.8.3 Global Exoskeleton Enhancement Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Exoskeleton Enhancement Device Market Scenario by Region
3.1 Global Exoskeleton Enhancement Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Exoskeleton Enhancement Device Sales by Region: 2021–2032
3.2.1 Global Exoskeleton Enhancement Device Sales by Region: 2021–2026
3.2.2 Global Exoskeleton Enhancement Device Sales by Region: 2027–2032
3.3 Global Exoskeleton Enhancement Device Revenue by Region: 2021–2032
3.3.1 Global Exoskeleton Enhancement Device Revenue by Region: 2021–2026
3.3.2 Global Exoskeleton Enhancement Device Revenue by Region: 2027–2032
3.4 North America Exoskeleton Enhancement Device Market Facts & Figures by Country
3.4.1 North America Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.4.3 North America Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Exoskeleton Enhancement Device Market Facts & Figures by Country
3.5.1 Europe Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.5.3 Europe Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Exoskeleton Enhancement Device Market Facts & Figures by Region
3.6.1 Asia Pacific Exoskeleton Enhancement Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Exoskeleton Enhancement Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Exoskeleton Enhancement Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Exoskeleton Enhancement Device Market Facts & Figures by Country
3.7.1 Latin America Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.7.3 Latin America Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Exoskeleton Enhancement Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Exoskeleton Enhancement Device Sales by Type (2021–2032)
4.1.1 Global Exoskeleton Enhancement Device Sales by Type (2021–2026)
4.1.2 Global Exoskeleton Enhancement Device Sales by Type (2027–2032)
4.1.3 Global Exoskeleton Enhancement Device Sales Market Share by Type (2021–2032)
4.2 Global Exoskeleton Enhancement Device Revenue by Type (2021–2032)
4.2.1 Global Exoskeleton Enhancement Device Revenue by Type (2021–2026)
4.2.2 Global Exoskeleton Enhancement Device Revenue by Type (2027–2032)
4.2.3 Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021–2032)
4.3 Global Exoskeleton Enhancement Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Exoskeleton Enhancement Device Sales by Application (2021–2032)
5.1.1 Global Exoskeleton Enhancement Device Sales by Application (2021–2026)
5.1.2 Global Exoskeleton Enhancement Device Sales by Application (2027–2032)
5.1.3 Global Exoskeleton Enhancement Device Sales Market Share by Application (2021–2032)
5.2 Global Exoskeleton Enhancement Device Revenue by Application (2021–2032)
5.2.1 Global Exoskeleton Enhancement Device Revenue by Application (2021–2026)
5.2.2 Global Exoskeleton Enhancement Device Revenue by Application (2027–2032)
5.2.3 Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021–2032)
5.3 Global Exoskeleton Enhancement Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cyberdyne
6.1.1 Cyberdyne Company Information
6.1.2 Cyberdyne Description and Business Overview
6.1.3 Cyberdyne Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
6.1.5 Cyberdyne Recent Developments/Updates
6.2 Hocoma
6.2.1 Hocoma Company Information
6.2.2 Hocoma Description and Business Overview
6.2.3 Hocoma Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
6.2.5 Hocoma Recent Developments/Updates
6.3 ReWalk Robotics
6.3.1 ReWalk Robotics Company Information
6.3.2 ReWalk Robotics Description and Business Overview
6.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
6.3.5 ReWalk Robotics Recent Developments/Updates
6.4 Ekso Bionics
6.4.1 Ekso Bionics Company Information
6.4.2 Ekso Bionics Description and Business Overview
6.4.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
6.4.5 Ekso Bionics Recent Developments/Updates
6.5 LockHeed Martin
6.5.1 LockHeed Martin Company Information
6.5.2 LockHeed Martin Description and Business Overview
6.5.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
6.5.5 LockHeed Martin Recent Developments/Updates
6.6 Parker Hannifin
6.6.1 Parker Hannifin Company Information
6.6.2 Parker Hannifin Description and Business Overview
6.6.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
6.6.5 Parker Hannifin Recent Developments/Updates
6.7 Interactive Motion Technologies
6.7.1 Interactive Motion Technologies Company Information
6.7.2 Interactive Motion Technologies Description and Business Overview
6.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
6.7.5 Interactive Motion Technologies Recent Developments/Updates
6.8 Panasonic
6.8.1 Panasonic Company Information
6.8.2 Panasonic Description and Business Overview
6.8.3 Panasonic Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
6.8.5 Panasonic Recent Developments/Updates
6.9 Myomo
6.9.1 Myomo Company Information
6.9.2 Myomo Description and Business Overview
6.9.3 Myomo Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Myomo Exoskeleton Enhancement Device Product Portfolio
6.9.5 Myomo Recent Developments/Updates
6.10 B-TEMIA Inc.
6.10.1 B-TEMIA Inc. Company Information
6.10.2 B-TEMIA Inc. Description and Business Overview
6.10.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
6.10.5 B-TEMIA Inc. Recent Developments/Updates
6.11 Alter G
6.11.1 Alter G Company Information
6.11.2 Alter G Description and Business Overview
6.11.3 Alter G Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Alter G Exoskeleton Enhancement Device Product Portfolio
6.11.5 Alter G Recent Developments/Updates
6.12 US Bionics
6.12.1 US Bionics Company Information
6.12.2 US Bionics Description and Business Overview
6.12.3 US Bionics Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
6.12.5 US Bionics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Exoskeleton Enhancement Device Industry Chain Analysis
7.2 Exoskeleton Enhancement Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Exoskeleton Enhancement Device Production Mode & Process Analysis
7.4 Exoskeleton Enhancement Device Sales and Marketing
7.4.1 Exoskeleton Enhancement Device Sales Channels
7.4.2 Exoskeleton Enhancement Device Distributors
7.5 Exoskeleton Enhancement Device Customer Analysis
8 Exoskeleton Enhancement Device Market Dynamics
8.1 Exoskeleton Enhancement Device Industry Trends
8.2 Exoskeleton Enhancement Device Market Drivers
8.3 Exoskeleton Enhancement Device Market Challenges
8.4 Exoskeleton Enhancement Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Exoskeleton Enhancement Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Exoskeleton Enhancement Device Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Exoskeleton Enhancement Device Market Competitive Situation by Manufacturers in 2025
Table 4. Global Exoskeleton Enhancement Device Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Exoskeleton Enhancement Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Exoskeleton Enhancement Device Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Exoskeleton Enhancement Device Average Price (K USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Exoskeleton Enhancement Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Exoskeleton Enhancement Device, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Exoskeleton Enhancement Device, Product Types and Applications
Table 12. Global Key Manufacturers of Exoskeleton Enhancement Device, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Exoskeleton Enhancement Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Exoskeleton Enhancement Device Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Exoskeleton Enhancement Device Sales by Region (Units), 2021–2026
Table 18. Global Exoskeleton Enhancement Device Sales Market Share by Region (2021–2026)
Table 19. Global Exoskeleton Enhancement Device Sales by Region (Units), 2027–2032
Table 20. Global Exoskeleton Enhancement Device Sales Market Share by Region (2027–2032)
Table 21. Global Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2021–2026
Table 22. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021–2026)
Table 23. Global Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2027–2032
Table 24. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2027–2032)
Table 25. North America Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 27. North America Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 28. North America Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 29. North America Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 32. Europe Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 33. Europe Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Exoskeleton Enhancement Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Exoskeleton Enhancement Device Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Exoskeleton Enhancement Device Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 42. Latin America Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 43. Latin America Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 50. Global Exoskeleton Enhancement Device Sales (Units) by Type (2021–2026)
Table 51. Global Exoskeleton Enhancement Device Sales (Units) by Type (2027–2032)
Table 52. Global Exoskeleton Enhancement Device Sales Market Share by Type (2021–2026)
Table 53. Global Exoskeleton Enhancement Device Sales Market Share by Type (2027–2032)
Table 54. Global Exoskeleton Enhancement Device Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Exoskeleton Enhancement Device Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021–2026)
Table 57. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2027–2032)
Table 58. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Type (2021–2026)
Table 59. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Type (2027–2032)
Table 60. Global Exoskeleton Enhancement Device Sales (Units) by Application (2021–2026)
Table 61. Global Exoskeleton Enhancement Device Sales (Units) by Application (2027–2032)
Table 62. Global Exoskeleton Enhancement Device Sales Market Share by Application (2021–2026)
Table 63. Global Exoskeleton Enhancement Device Sales Market Share by Application (2027–2032)
Table 64. Global Exoskeleton Enhancement Device Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Exoskeleton Enhancement Device Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021–2026)
Table 67. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2027–2032)
Table 68. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Application (2021–2026)
Table 69. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Application (2027–2032)
Table 70. Cyberdyne Company Information
Table 71. Cyberdyne Description and Business Overview
Table 72. Cyberdyne Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 73. Cyberdyne Exoskeleton Enhancement Device Product
Table 74. Cyberdyne Recent Developments/Updates
Table 75. Hocoma Company Information
Table 76. Hocoma Description and Business Overview
Table 77. Hocoma Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 78. Hocoma Exoskeleton Enhancement Device Product
Table 79. Hocoma Recent Developments/Updates
Table 80. ReWalk Robotics Company Information
Table 81. ReWalk Robotics Description and Business Overview
Table 82. ReWalk Robotics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 83. ReWalk Robotics Exoskeleton Enhancement Device Product
Table 84. ReWalk Robotics Recent Developments/Updates
Table 85. Ekso Bionics Company Information
Table 86. Ekso Bionics Description and Business Overview
Table 87. Ekso Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 88. Ekso Bionics Exoskeleton Enhancement Device Product
Table 89. Ekso Bionics Recent Developments/Updates
Table 90. LockHeed Martin Company Information
Table 91. LockHeed Martin Description and Business Overview
Table 92. LockHeed Martin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 93. LockHeed Martin Exoskeleton Enhancement Device Product
Table 94. LockHeed Martin Recent Developments/Updates
Table 95. Parker Hannifin Company Information
Table 96. Parker Hannifin Description and Business Overview
Table 97. Parker Hannifin Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 98. Parker Hannifin Exoskeleton Enhancement Device Product
Table 99. Parker Hannifin Recent Developments/Updates
Table 100. Interactive Motion Technologies Company Information
Table 101. Interactive Motion Technologies Description and Business Overview
Table 102. Interactive Motion Technologies Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 103. Interactive Motion Technologies Exoskeleton Enhancement Device Product
Table 104. Interactive Motion Technologies Recent Developments/Updates
Table 105. Panasonic Company Information
Table 106. Panasonic Description and Business Overview
Table 107. Panasonic Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 108. Panasonic Exoskeleton Enhancement Device Product
Table 109. Panasonic Recent Developments/Updates
Table 110. Myomo Company Information
Table 111. Myomo Description and Business Overview
Table 112. Myomo Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 113. Myomo Exoskeleton Enhancement Device Product
Table 114. Myomo Recent Developments/Updates
Table 115. B-TEMIA Inc. Company Information
Table 116. B-TEMIA Inc. Description and Business Overview
Table 117. B-TEMIA Inc. Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 118. B-TEMIA Inc. Exoskeleton Enhancement Device Product
Table 119. B-TEMIA Inc. Recent Developments/Updates
Table 120. Alter G Company Information
Table 121. Alter G Description and Business Overview
Table 122. Alter G Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 123. Alter G Exoskeleton Enhancement Device Product
Table 124. Alter G Recent Developments/Updates
Table 125. US Bionics Company Information
Table 126. US Bionics Description and Business Overview
Table 127. US Bionics Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (K USD/Unit), and Gross Margin (2021–2026)
Table 128. US Bionics Exoskeleton Enhancement Device Product
Table 129. US Bionics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Exoskeleton Enhancement Device Distributors List
Table 133. Exoskeleton Enhancement Device Customers List
Table 134. Exoskeleton Enhancement Device Market Trends
Table 135. Exoskeleton Enhancement Device Market Drivers
Table 136. Exoskeleton Enhancement Device Market Challenges
Table 137. Exoskeleton Enhancement Device Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Exoskeleton Enhancement Device
Figure 2. Global Exoskeleton Enhancement Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Exoskeleton Enhancement Device Market Share by Type: 2025 & 2032
Figure 4. Lower Product Picture
Figure 5. Upper Product Picture
Figure 6. Full Body Product Picture
Figure 7. Global Exoskeleton Enhancement Device Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Exoskeleton Enhancement Device Market Share by Application: 2025 & 2032
Figure 9. Healthcare
Figure 10. Defense
Figure 11. Others
Figure 12. Global Exoskeleton Enhancement Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Exoskeleton Enhancement Device Market Size (US$ Million), 2021–2032
Figure 14. Global Exoskeleton Enhancement Device Sales (Units), 2021–2032
Figure 15. Global Exoskeleton Enhancement Device Average Price (K USD/Unit), 2021–2032
Figure 16. Exoskeleton Enhancement Device Report Years Considered
Figure 17. Exoskeleton Enhancement Device Sales Share by Manufacturers in 2025
Figure 18. Global Exoskeleton Enhancement Device Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Exoskeleton Enhancement Device Players: Market Share by Revenue in Exoskeleton Enhancement Device in 2025
Figure 20. Exoskeleton Enhancement Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 23. North America Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 27. Europe Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 28. Germany Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Exoskeleton Enhancement Device Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Exoskeleton Enhancement Device Revenue Market Share by Region (2021–2032)
Figure 35. China Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 46. Latin America Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Exoskeleton Enhancement Device by Type (2021–2032)
Figure 56. Global Revenue Market Share of Exoskeleton Enhancement Device by Type (2021–2032)
Figure 57. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Exoskeleton Enhancement Device by Application (2021–2032)
Figure 59. Global Revenue Market Share of Exoskeleton Enhancement Device by Application (2021–2032)
Figure 60. Global Exoskeleton Enhancement Device Price (K USD/Unit) by Application (2021–2032)
Figure 61. Exoskeleton Enhancement Device Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
